Healthcare Royalty postponed IPO
6 August Healthcare Royalty, which buys royalties on tradable and late-stage biopharmaceuticals, announced the decision to postpone the upcoming IPO. The company has applied for attraction 750 million dollars, releasing 46,9 million shares (33% secondary) at a price from 15 to 17 Dollars.